Healthcare systems across the globe continue to meet difficulties with new diseases that pose a severe danger to society. Methicillin-resistant Staphylococcus aureus (MRSA) is a highly infectious and challenging-to-control pathogen with high mortality rates since it comes from an adaptation of a regular SA to antibiotics (Pannewick et al., 2021). The associated illness puts a significant strain on healthcare facilities, which is further worsened by the differences in recommendations against MRSA propagation. Current methods of controlling the spread of MRSA may require further upgrades, as there are outbreaks that continue to occur.
Modern methods against MRSA prioritize several critical points of its appearance and transmission. The primary measure in case of MRSA appearance is the activation of search-and-destroy protocols against its further dissemination, while settings that are affected by this pathogen are also prompted to utilize MRSA guidelines for personal protection equipment (Pannewick et al., 2021). These methods prevent MRSA’s activities further by blocking its transmission paths. Furthermore, farm animals treated with antibiotics that led to this mutation become a target of MRSA control measures through adjusted guidelines for drug application (Schulz et al., 2019). While this approach is beneficial for the timely termination of MRSA sources, it has its downsides, such as its reactionary nature. Changes, such as decreased application of antibiotics among farm animals and increased screening rates of vulnerable populations, can reduce MRSA occurrence rates, despite their financial burden.
In conclusion, MRSA is a deadly pathogen that is resistant to eradication and burdens healthcare systems across the globe. MRSA is prevented via isolation and termination, as well as through heightened protection measures. The current systems of MRSA control require updates due to the type of response, which should become more proactive than it is now. Non-selective screening approaches can provide a high level of protection against MRSA, despite the implications of increased expenditures.
References
Pannewick, B., Baier, C., Schwab, F., & Vonberg, R. (2021). Infection control measures in nosocomial MRSA outbreaks—Results of a systematic analysis. PLOS ONE, 16(4). Web.
Schulz, J., Boklund, A., Toft, N., & Halasa, T. (2019). Effects of control measures on the spread of LA-MRSA among Danish pig herds between 2006 and 2015 – a simulation study. Scientific Reports, 9(1). Web.